TickerFacts.

Haemonetics Corp (HAE): Capital Expenditures

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2023-04-01 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$32.78M
Year ended 2026-03-28
$36.93M
Trailing 12 months to 2026-06-27
-44.5%
3-year compound annual growth
$191.33M2009-03-28: $56.38M2010-04-03: $56.30M2011-04-02: $46.67M2012-03-31: $53.20M2013-03-30: $62.19M2014-03-29: $73.65M2015-03-28: $122.22M2016-04-02: $102.41M2017-04-01: $76.14M2018-03-31: $74.80M2019-03-30: $118.96M2020-03-28: $48.76M2021-04-03: $37.04M2022-04-02: $96.51M2023-04-01: $191.33M2024-03-30: $38.12M2025-03-29: $39.28M2026-03-28: $32.78M$32.78M
2009-03-28 Capital Expenditures (USD) 2026-03-28
Period endedCapital ExpendituresChange YoYSource filing
2026-03-28$32.78M-16.5%2026-05-20, From 2025-03-30
2025-03-29$39.28M+3.0%2026-05-20, From 2024-03-31
2024-03-30$38.12M-80.1%2026-05-20, From 2023-04-02
2023-04-01$191.33Mn/c2025-05-21, From 2022-04-03
2022-04-02$96.51M+160.6%2024-05-20, From 2021-04-04
2021-04-03$37.04M-24.0%2023-05-22, From 2020-03-29
2020-03-28$48.76M-59.0%2022-05-25, From 2019-03-31
2019-03-30$118.96M+59.0%2021-05-26, From 2018-04-01
2018-03-31$74.80M-1.8%2020-05-20, From 2017-04-02
2017-04-01$76.14M-25.7%2019-05-22, From 2016-04-03
2016-04-02$102.41M-16.2%2018-05-23, From 2015-03-29
2015-03-28$122.22M+66.0%2017-05-24, From 2014-03-30
2014-03-29$73.65M+18.4%2016-06-01, From 2013-03-31
2013-03-30$62.19M+16.9%2015-05-22, From 2012-04-01
2012-03-31$53.20M+14.0%2014-05-22, From 2011-04-03
2011-04-02$46.67M-17.1%2013-05-20, From 2010-04-04
2010-04-03$56.30M-0.1%2012-05-22, From 2009-03-29
2009-03-28$56.38Mn/a2011-05-26, From 2008-03-30

Capital Expenditures at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Haemonetics Corp (HAE)2026-03-28$32.78M-16.5%
Penumbra Inc (PEN)2025-12-31$63.73M+200.9%
Merit Medical Systems Inc (MMSI)2025-12-31$81.72M+132.5%
Integra Lifesciences Holdings Corp (IART)2025-12-31$81.44M-22.0%
Embecta Corp. (EMBC)2025-09-30$9.30M-41.1%
Tandem Diabetes Care Inc (TNDM)2025-12-31$19.95M+3.7%
Inspire Medical Systems, Inc. (INSP)2025-12-31$38.50M-1.6%
Teleflex Inc (TFX)2025-12-31$95.24M+5.3%
Orthofix Medical Inc. (OFIX)2025-12-31$34.63M-0.7%

Compare HAE, PEN, MMSI, IART side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗